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A B S T R A C T
One Health is deﬁned as the intersection and integration of knowledge regarding humans, animals, and the
environment, yet as the One Health scientiﬁc literature expands, there is considerable heterogeneity of approach
and quality of reporting in One Health studies. In addition, many researchers who publish such studies do not
include or integrate data from all three domains of human, animal, and environmental health. This points to a
critical need to unify guidelines for One Health studies. This report details the Checklist for One Health
Epidemiological Reporting of Evidence (COHERE) to guide the design and publication format of future One
Health studies. COHERE was developed by a core writing team and international expert review group that
represents multiple disciplines, including human medicine, veterinary medicine, public health, allied profes-
sionals, clinical laboratory science, epidemiology, the social sciences, ecohealth and environmental health. The
twin aims of the COHERE standards are to 1) improve the quality of reporting of observational or interventional
epidemiological studies that collect and integrate data from humans, animals and/or vectors, and their en-
vironments; and 2) promote the concept that One Health studies should integrate knowledge from these three
domains. The 19 standards in the COHERE checklist address descriptions of human populations, animal popu-
lations, environmental assessment, spatial and temporal relationships of data from the three domains, integra-
tion of analyses and interpretation, and inclusion of expertise in the research team from disciplines related to
human health, animal health, and environmental health.
1. Introduction
With the increased recognition that diseases often emerge out of
interactions of human, animal, and environmental factors, a new ap-
proach to address these issues has arisen, known as One Health. The
roots of this paradigm lie in the fertile grounds of comparative pa-
thology, driven by the remarkable eﬀorts, perspectives, and writings of
William Osler, Calvin Schwabe, Rudolf Virchow, and many others [1].
This early foundation, focused mainly on the “one medicine”
intersection of human and animal health, has grown into an eﬀort that
also incorporates preventative medicine and public health approaches,
particularly environmental health and ecohealth [2]. In recent years,
One Health has been described as “the collaborative eﬀort of multiple
disciplines — working locally, nationally, and globally — to attain
optimal health for people, animals and our environment” [3]. The One
Health approach, therefore, involves combined assessment of health
risks across the three domains of humans, animals, and the environ-
ment, and it involves design and implementation of intervention and
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prevention strategies that address all three sectors with a goal to pro-
duce integrated knowledge [4].
A One Health approach, by deﬁnition, encompasses many ﬁelds,
and these include, but are not limited to, infectious diseases, chronic
diseases, toxicology, ecology, agriculture and sustainability, conserva-
tion medicine, economics, anthropology, ethnography, and the social
sciences. The approach can inform eﬀorts to develop and implement
studies or programs related to human and animal wellness, mental
health and wellbeing, and the human-animal bond. However, the ﬁelds
in question often are segregated by methodology, funding, and pub-
lication [5]. Requirements from funding sources and publication silos
may contribute to the fracture of One Health studies into multiple,
discipline-speciﬁc studies and/or publications. At the same time, the
term “One Health” has become increasingly common in the biomedical
literature (Fig. 1). As the literature expands, authors of this document
and contributing experts who have conducted systematic reviews have
noted considerable heterogeneity of approach and quality of reporting
in One Health studies [4,6,7]. Such lack of consensus on criteria that
constitute a well-designed and clearly-presented One Health study
jeopardizes the impact of this growing ﬁeld and limits the ability of the
reader to judge the strengths and limitations of this literature.
To build on the foundation of scholarship and provide scope and
guidance for future work, we propose the following Checklist for One
Health Epidemiological Reporting of Evidence (COHERE) for research
publications classiﬁed as One Health studies. We intend this work to
apply primarily to the approach and reporting of observational and
interventional One Health studies that employ epidemiological
methods (see Box 1), although these guidelines may also beneﬁt other
One Health study designs. Given that interdisciplinary work can serve
as an incubator for innovation, we further intend this checklist to be a
living document informed by iterative feedback from authors, editors,
and readers of the One Health literature.
2. Aims and use of the COHERE standards
The Checklist for One Health Epidemiological Reporting of Evidence
(COHERE) provides a set of standards that should be included in articles
reporting on the results of One Health studies that use epidemiological
methods. Box 1 provides a glossary of terms that may be useful to those
who will use these standards.
The twin aims of COHERE are to 1) improve the quality of reporting
of observational or interventional epidemiological studies that collect
and integrate data from humans, animals and/or vectors, and their
Fig. 1. Number of papers published per year identiﬁed with the search terms “One
Health” or “One Medicine” in Pubmed (1927–2016).
Box 1
Glossary of key terms used in the standards and text.
Ecohealth: an integrated systemic approach to health incorporating the sustainability of ecosystem health services and social stability to
maintain peaceful coexistence of humans, animals and their environments [27].
Captive exotic animal: An animal of a non-domesticated species that is living under human control.
Domestic animal: Companion and food-producing species that have lived for many generations with humans and whose characteristics
and traits are generally considered to be under human control.
Epidemiological studies: Studies that determine the distribution of diseases in populations and the factors that may drive this dis-
tribution.
Free-ranging wild animal: An animal of a non-domesticated species that is living largely outside of human control.
Generalizability: applicability of research study ﬁndings from a sample population to the larger, target population.
Inter-professional education: training approach that brings together and fosters collaboration among students of various disciplines in
order to enhance collaboration and promote acquisition of interdisciplinary knowledge.
Qualitative data: data that are non-numerical.
Quantitative data: numerical data.
Semi-qualitative data: data that have a numerical hierarchy but are presented in terms of categories or scales.
Signalment: An animal's age, sex, species and breed.
Fig. 2. Venn diagram illustrating the three domains of One Health. (A) Epidemiological
studies relating factors between animal and human health; (B) Epidemiological studies
relating factors between environmental and human health; (C) Epidemiological studies
relating factors between animal and environmental health.
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Box 2
Deﬁnition of the Three Domains.
Although the three domains of humans, animals and the environment are quite broad, their application in a One Health context requires
speciﬁc focus on health-related aspects of these sectors (see Fig. 2). That said, since health, as deﬁned by the World Health Organization, is
“a state of complete physical, mental, and social well-being and not merely the absence of disease or inﬁrmity,” this allows for evaluation of
not just disease factors, but well-being, societal resilience, and other beneﬁcial aspects [28]. For example, the human-animal bond may
reduce human and animal stress; safe and walkable neighborhoods may promote greater activity and reduced obesity in human and
companion animal inhabitants; and preservation of ecosystem services may improve resilience of human and animal populations threa-
tened by changes in climate. COHERE standards allow for authors whose work may not fall into traditional deﬁnitions of human health,
animal health, and environmental health to describe and defend the deﬁnitions used for the study being reported. It is then incumbent upon
editors, reviewers, and readers to determine if any non-traditional deﬁnitions are reasonable and justiﬁed.
The COHERE standards require that studies report data in all three domains, but sometimes, the boundary between domains may not be
sharply delineated. Vectors are particularly problematic to classify. The term itself has multiple deﬁnitions that encompass the ﬁelds of
mathematics, computer science, and biology. This can challenge accurate communication in a scientiﬁc arena as multidisciplinary as One
Health. For the purposes of these standards, we will use two diﬀerent deﬁnitions of vector: 1) mechanical vector, and 2) biological vector. In
both these cases, invertebrate arthropods (i.e., insects and arachnids) operate in the context of transmission of infectious agents from one
host to another. However, some deﬁnitions of mechanical vector also include inanimate fomites that move, such as vehicles. The diversity
of research that surrounds insect vectors and vector-borne diseases can cloud consensus on whether vectors should be considered in the
animal domain or environmental domain.
Mechanical vectors, which more appropriately fall in the environmental domain, transfer infectious agents, chemicals, or other sub-
stances from one point in the environment to another point in the environment, much the same way a car could transfer or disperse a
substance it contacts. When a research group considers vectors in this way, we argue that these data should be grouped with other
environmental variables or treated as ﬁndings from a fomite. Biological vectors, in contrast, are part of an ecosystem or are part of the
lifecycle of an infectious agent. They are living members of communities, and when researchers evaluate them as such and target their
biology and not just their carriage of a pathogen, may belong in the sector with animals. Consider the example of malaria, a well-studied
vector-borne disease. Research Group A studies how changes in the geographic dispersal of mosquitoes that correlate with changes in
temperature and humidity result in changes to the geographic dispersal of malaria in human populations. In this case, COHERE would
group data on the geographic distribution of mosquito populations with the environmental sector. Research Group B instead studies how
temperature and humidity impact mosquito fecundity and the extrinsic incubation period of the malaria parasite within the mosquitoes.
COHERE would group these data on the mosquitoes with the animal sector.
Box 3
Incorporation of the Three Domains.
The COHERE standards advocate that studies which purport to be “One Health” in nature should present data from human, animal, and
environmental domains of the problem, as illustrated in Fig. 2. However, a recent systematic review of integrated parasite surveillance
identiﬁed more publications that integrated two One Health sectors than those that addressed all three [7]. Studies integrating human and
animal data (illustrated as zone A in Fig. 2) appear to be most common, and report useful information that includes, but is not limited to,
diﬀerences in prevalence, clinical features, and local reservoirs for infection. However, these studies (illustrated as zones A, B, and C in
Fig. 2) represent a missed opportunity to present a complete picture of disease transmission, and may adversely aﬀect pathogen control
interventions due to unexpected pathogen dynamics in the uncharacterized One Health domain, whichever one that is.
By following the COHERE standards, investigators will be encouraged to include data about the human, animal, and environmental
health domains of a particular disease or health issue. Authors who have completed data collection in only two of the three domains, or who
do not have access to one of the three domains for a variety of reasons may still beneﬁt from consideration of as many of the COHERE
standards that apply to their work. Indeed, such studies may be necessary precursors to the successful launch of a One Health study, and the
data derived from these eﬀorts often are critical to inform interpretation of the results of subsequent One Health research. Therefore, this
group makes a number of suggestions for how to use and incorporate the COHERE standards when only two of the three domains are well
represented, as described in Table 2. As long as the research group incorporates expertise from all three domains and applies this multi-
disciplinary expertise diligently to the study design, conduct of the research, and interpretation of the ﬁndings, then use of partial data or
surrogate assessment of one of the domains would not disqualify the research from being considered a One Health study. (N.B.: In con-
sidering expertise, individual researchers may have the background needed to represent more than one domain.) While some studies may
be diﬃcult to categorize, a necessary component to reporting a One Health study is explicit incorporation of all three domains in the
introduction, methods, results, and discussion of the manuscript. Studies where authors reference the literature on an otherwise neglected
third domain in the introduction and discussion alone do not fulﬁll the standards. This group recommends that studies that 1) cannot fulﬁll
the majority of the standards and 2) do not have the necessary component of data reporting on all three domains as described above should
not formally claim to be One Health studies, e.g., in the title or keywords. Nonetheless, these research eﬀorts are important and can be
foundational to later One Health research eﬀorts, and authors are encouraged to discuss One Health implications and position their ﬁndings
within the larger One Health literature.
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Table 1
The COHERE standards.
Item Standard number Recommendation
Introduction
Background 1 Review the human, animal, and environmental context of the problem and justify why a One Health study is appropriate to
address the scientiﬁc question
Rationale 2 Clearly state the research aims and/or hypotheses in the context of the relationship among the three domains (human, animal
and environment), or state and defend the nature of the study if it is not hypothesis-driven
Methods
Study design 3 (a) Explain or describe the relationship/interaction (epidemiologic, biological, ecological, spatial/temporal, etc.) of the
collection of the human, animal, and environmental specimens and/or dataa
(b) Provide inclusion and exclusion criteria for all domains
(c) According to study design, follow other guidance, e.g. STROBE and its extensions (STROBE-VET, STROME-ID), CONSORT,
PRISMA, etc., as indicated
Human participants 4 (a) Provide qualitative and/or quantitative description of the human population or human data, including characteristics
related to inclusion or exclusion from the study, sample size (at all relevant population levels), and sample size
justiﬁcation, as appropriate
(b) Ensure human subject assurances adhere to the highest standards of ethics governing human subjects research
Animal participantsb 5 (a) Provide qualitative and/or quantitative description of the animal population (domestic, captive exotic, or free-ranging
wild), including characteristics related to inclusion or exclusion from the study, sample size (at all relevant population
levels), and sample size justiﬁcation
(b) Include, at minimum, the common or generic name for the species of animal or animals studied, and provide the taxonomic
Genus species if indicated (i.e. for less common species) if the species chosen is dependent on study designa
(c) Ensure animal subject assurances adhere to the highest standards of ethics governing animal subjects research
Environmentb 6 (a) Identify environmental (abiotic) and/or ecosystem (biotic) factors including vector characteristicsb if appropriate, that
are under investigation
(b) Describe the type and purpose of any environmental samples or data collected
(c) Provide qualitative and/or quantitative description of the study location, including geographic locale (e.g. region and
country, latitude/longitude or a centralized point if the location of the site is sensitive information), ecosystem type (e.g.
mangrove forest) and/or land use description (e.g. urban, agricultural, etc.), and number and description of where samples
were obtainedb
Measurement 7 (a) If indicated, include the frequency of sampling (i.e. sample interval) and calendar timing (i.e. date, month, season, year)b
(b) Describe the relationships/interactions (epidemiologic, biological, ecological, spatial/temporal, etc.) among human,
animal, and environmental samples and data, as well as other signiﬁcant diﬀerences in data collection methods between
domainsa
(c) Describe and justify testing or analysis measures used, and indicate the validity for such measurements for use among
human, animal and environmental domains
Analysis 8 (a) Identify how data among the three domains were collected
(b) Explain how any hierarchical relationships within and between domains (e.g. at the individual or group level) were handled
(c) If data were handled diﬀerentially among the three domains (e.g. collection of data from one domain at a diﬀerent time
interval than from another domain), describe this in suﬃcient detail to allow assessment of potential bias introduced by this
decisiona
Study team 9 (a) If applicable, describe the involvement of study team members, stakeholders and community members (e.g. farmer
participant stakeholders, industry, etc.)
(b) Indicate how study team members representing all three domains contributed to development of the research question and
study design
Ethics 10 (a) Report animal (IACUC/ACUC) and human ethics (IRB) approvals, as well as other relevant permissions that were
obtained
(b) If applicable, describe the framework for adhering to community based research standards (e.g. community approval,
cultural respect, knowledge translation)
Results
Human participants 11 (a) Report recruitment data, provide study population percentages and describe generalizability of study population to
underlying population
(b) Describe demographics (i.e. sex, age, race/ethnicity, etc.) or case characteristics, as well as exposure factors and behavioral
characteristics evaluated, of human subjectsc
Animal participants 12 (a) Report study population percentages and describe generalizability of study population and study species to the
underlying animal population of interest
(b) Describe demographics (i.e. sex, age, breed, etc.) or signalment, as well as exposure factors, of animal subjects
(c) If applicable, describe animal management characteristics (i.e. housing, diet, other environmental factors)
Environment 13 (a) Report ﬁndings from collected samples and/or measurements, including measures of heterogeneity that could impact
generalizability of ﬁndings
(b) Provide descriptive statistics for all appropriate environmental/ecosystem variables
(c) If appropriate, provide geographic referencing for all samples or data submitted to public databases
Measurement 14 (a) Identify populations, pathogens and/or vectors to the same taxonomic level across all three domains
(b) Report ﬁndings in a way that is standardized or equivalent across all three domains
Analysis 15 (a) Provide comparative statistics, qualitative comparisons or integrated analyses among human, animal, and environmental
variables, including (as appropriate) measures or descriptions of uncertainty (e.g. variance, conﬁdence intervals,
qualitative limitations)
(b) Consider the potential for lack of independence or group eﬀects that may impact statistical inference (e.g. at the household
or building level, pen or other animal cohort level, and community level)
(c) If indicated, provide geospatial comparisons or illustrations of spatial relationships (e.g. maps) to describe the distribution
between human and animal populations
Discussion
Overall 16 (a) Provide a comprehensive discussion that integrates the human, animal and environmental aspects of the results
(b) Indicate generalizability of ﬁndings to local, national, and/or international levels
(continued on next page)
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environments (the One Health domains); and 2) promote the concept
that One Health studies should integrate knowledge from all three of
these domains. Fig. 2 oﬀers an illustration of this concept, which is
further explained in Box 2 (Deﬁnition of the Three Domains) and Box 3
(Incorporation of the Three Domains). We intend this guidance to aid,
not only to report data at the point of manuscript preparation, but to
design and plan studies, since certain criteria not obtained or observed
during the execution of the study cannot be corrected at the reporting
stage. While the scope of this document and these standards is limited
to epidemiological studies (aim 1), the concept that all One Health
studies should strive to integrate knowledge from human, animal, and
environmental domains (aim 2) can be applied regardless of study
methodology.
3. Development of the COHERE standards
The COHERE standards were developed by a multidisciplinary core
team of experts who determined the process for standard development,
drafted the initial checklist, and chose the membership of the COHERE
expert review group. This review group was an extended panel of ex-
perts who individually and jointly reviewed the standards and whose
feedback was incorporated by the core team. The COHERE expert re-
view group was chosen to represent both professional and global di-
versity in the ﬁeld. Experts in the conduct of One Health epidemiolo-
gical studies were included from human medicine, veterinary medicine,
public health, allied professionals, clinical laboratory science, eco-
health, and environmental health. By design, multiple institutions and
countries were represented in the core team and expert review group.
The structure of the COHERE checklist was designed to closely
follow the model of STROBE and its extensions, with the intention that
authors of One Health manuscripts should additionally follow these and
related standards where appropriate [8,9]. The COHERE checklist is
intended to cover content description felt to be critical to report and
interpret studies conducted at the intersection of human, animal, and
environmental health.
4. The COHERE standards
Table 1 provides the checklist of standards that should be con-
sidered when undertaking, reporting, and reviewing “One Health”
epidemiological studies with the goal to produce integrated knowledge.
The 19 standards encompass the approach and reporting of ﬁndings
related to the following manuscript sections: Introduction [1-2],
Methods [3-10], Results [11-15], Discussion [16-17], One Health con-
tribution [18], and acknowledgements [19]. As indicated in the stan-
dards, authors should additionally follow other guidance documents,
e.g., STROBE and its extensions (STROBE-VET, STROME-ID, etc.),
CONSORT, PRISMA, in accord with the study design [10–15]. Authors
should use these standards as guidance for the types of information to
include in a manuscript, but not as a constraint to the narrative ﬂow of
the text. For example, authors are not required to report human, an-
imal, and environmental data separately if an integrated presentation
will be more clear for the reader, nor are they required to combine all
ﬁndings into a single construct if the data are better presented using
separate table or ﬁgures.
5. Assessment of the COHERE standards
Given the anticipated evolution of the ﬁeld, driven by inter-
disciplinary collaboration and innovation, and given expected feedback
from diverse users, the COHERE checklist is intended to be a living
document. Authors, editors and readers may provide suggestions to the
corresponding authors. The online checklist of standards will be up-
dated as needed at intervals driven by input from users or advances in
the ﬁeld [16].
6. Discussion
Adoption of One Health approaches is growing, driven in part by the
inherent integration of diverse disciplines and in part through the
emergence of ﬁnancial and resource support for policy and program
initiatives, educational programs, and research [17–20]. However, such
growth may be constrained by the preferences of journal editors,
boundaries on resources, lack of sustainable government commitment,
and a paucity of international educational opportunities
[5,17,18,20–22]. As One Health re-emerges as a top priority for those
involved in the mitigation of diseases and promotion of wellness, it is
important to recognize the challenges faced by those who work colla-
boratively to integrate the knowledge of multiple disciplines. Examples
of such challenges may include budget, competing timelines, long-term
Table 1 (continued)
Item Standard number Recommendation
Limitations 17 (a) Discuss any discordance in acquisition, analysis or interpretation of data among the three domains (e.g. identify problems
with application of diﬀerent methods among the domains)
(b) Identify where methods lack validation (e.g. animal methods used in human populations or vice versa)
(c) Identify any methods that may not have been optimal to address research aims and suggest how future studies could
overcome such limitations
(d) Comment on issues that may impact the reproducibility of the study, as appropriate
(e) Identify and discuss potential sources of bias
(f) Discuss species-speciﬁc diﬀerences that may impact the results or the interpretation of the results
(g) Identify other potential populations of humans or animals that could be involved in the problem and were not measured or
addressed in the study
One Health
Contribution
18 (a) Describe how a One Health approach to the study—speciﬁcally incorporation of expertise among the disciplines and
integration of ﬁndings from human, animal and environmental domains—furthered the understanding of the data/
research problem
(b) If appropriate, describe lessons learned from the One Health interdisciplinary study team approach, e.g. successes and
challenges identiﬁed as part of the process of conducting the study, methods for operationalizing participation among the
disciplines, and cost-beneﬁt analyses of the resource eﬃciencies of One Health studies
(c) Identify how the conclusions relate to promotion of human, animal and ecosystem health
(d) Include “One Health” as a keyword and, if appropriate, also in the title of the manuscript
Acknowledgment 19 Indicate funding source(s) and potential conﬂicts of interest
a Please adhere closely to STROBE or extension (e.g. STROBE-VET, STROME-ID, etc.) guidelines for reporting of observational epidemiology studies, which may impact placement of
these COHERE checklist data. Where indicated, data should be placed in methods or results sections per STROBE guidance.
b Please see additional discussion of deﬁnitions of biological vectors and when and how to report them as part of the animal participants or part of the environment.
c The authors and working group strongly encourage collection of and consideration of additional data on human subjects as appropriate, particularly occupation/work-related
exposures, socioeconomic parameters, and other community parameters.
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sustainability, data sharing, media contact, language and/or culture
diﬀerences, and synching research interests. Policy makers and aca-
demic leaders can alleviate some pressures of multi-disciplinary colla-
boration through the introduction of data-sharing agreements between
governmental agencies, by the promotion of opportunities for inter-
professional education [23], and by the prioritization of funding for
research teams composed of members from diﬀerent ﬁelds. Institutional
animal and human research ethics committees—such as the Institu-
tional Care and Use Committee (IACUC) and Institutional Review Board
(IRB)—can collaborate to improve oversight of One Health studies [24].
Studies that monitor the eﬀectiveness of One Health approaches are
underrepresented in the literature to date [4,6]. To overcome this,
authors of One Health studies can contribute to the evidence for the
cost-eﬀectiveness and eﬃcacy of integrated approaches to investigation
and intervention among the three domains by including such outputs in
the report of their ﬁndings.
If a One Health approach is to continue to thrive, it also will require
a shift within academia to recognize the eﬀorts and rewards of inter-
disciplinary collaborations that may take more time to complete, re-
quire more initial funding or resource investment, and require shared
credit by multiple investigators. This includes a shift away from “pub-
lication splitting,” a temptation for academics who rely on a productive
publication record to compete for tenure and promotion [7]. Shared
lead and senior authorship may be one solution to overcome such
challenges when ﬁndings are presented in an integrated fashion rather
than piecemeal in journals speciﬁc to the discipline of the expertise
groups within the research team. In addition, authors may contend with
preferences of journal editors who give priority to manuscripts with
more discipline-speciﬁc focus. The emergence of journals focused on
One Health studies provides one avenue for publication where in-
tegrated manuscripts have priority [25].
The COHERE standards are designed to strengthen the quality of
reporting of One Health observational or interventional epidemiolo-
gical studies that integrate knowledge and expertise from all three
domains. This process challenges authors, editors, and readers to
support eﬀorts to break down publication silos, improve collaborative
reporting, and foster innovation. (See Box 3 for additional discussion
of how to undertake and report studies focused on only two of the
three domains.) The types of studies that will employ COHERE stan-
dards are likely to be quite diverse. Data may be quantitative, semi-
quantitative, qualitative, or a combination, and study designs may be
retrospective or prospective. The study ﬁndings may be pertinent to
local, national, or international scales, and the work may be con-
ducted in both well-served and underserved areas. Diseases tackled
using a One Health approach are not limited to infection outcomes in
humans caused by zoonotic pathogens. Studies may include a wide
clinical spectrum of both acute and chronic diseases in animals as well
as humans, or they may consider ecosystem and planetary health.
Hence, authors of One Health studies will need to be careful to avoid
jargon and to emphasize clarity in communication that can bridge the
various disciplines involved in the ﬁeld. Some One Health expert
groups have endorsed involvement of communication specialists in
this eﬀort [26].
These standards are not intended to constrain the evolution of the
ﬁeld nor to limit One Health research funding. Given the intrinsic
multidisciplinary nature of the ﬁeld, it is perhaps inevitable that the
number of disciplines represented by researchers in this arena will in-
crease and include some areas of expertise less well represented in the
health disciplines, e.g., the earth sciences and engineering. As a result,
the standards may have to be adapted to new perspectives. Our author
group invites feedback via communication with the corresponding au-
thor, and we will iteratively update the checklist of standards. We also
encourage development of extensions to COHERE for other study de-
signs, such as basic research, mathematical modeling, systematic and
narrative literature reviews, economic analyses, program evaluation,
the social sciences, policy and law. As the acceptance and adoption of a
One Health approach continues to grow, the criteria used to conduct
and report research studies should grow with it.
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